Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(3.16) per share which missed the analyst consensus estimate of $(0.38) by 731.58 percent. This is a 1480 percent decrease over losses of $(0.20) per share from the same period last year. The company reported $789.000 thousand in sales this quarter. This is a 60.69 percent increase over sales of $491.000 thousand the same period last year.